Viracta Therapeutics Announces Wind Down of Operations
SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company…
0,078$
-48,65%
Echtzeit-Aktienkurs Viracta Therapeutics Inc.
Bid:
Ask:
Nachrichten zur Viracta Therapeutics Inc. Aktie
Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives
SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company…